Loading…
HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey
Highlights COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment. Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor...
Saved in:
| Published in: | Journal of medical virology 2020-11, Vol.92 (11), p.2288-2290 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c4615-2d90723d43fd6a69530dc492a20afaef69e4575da12e15bc23f6d1076a2089643 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4615-2d90723d43fd6a69530dc492a20afaef69e4575da12e15bc23f6d1076a2089643 |
| container_end_page | 2290 |
| container_issue | 11 |
| container_start_page | 2288 |
| container_title | Journal of medical virology |
| container_volume | 92 |
| creator | Altuntas Aydin, Ozlem Kumbasar Karaosmanoglu, Hayat Kart Yasar, Kadriye |
| description | Highlights
COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment.
Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases.
Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals. |
| doi_str_mv | 10.1002/jmv.25955 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2446986419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2446986419</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4615-2d90723d43fd6a69530dc492a20afaef69e4575da12e15bc23f6d1076a2089643</originalsourceid><addsrcrecordid>eNp1kMtKw0AUQAdRbK0u_AEJuBJMO-903JWiNlIRbO12mGZmILVN4kyidOcn-I1-iaOp7tzcuzmcezkAnCLYRxDiwWrz2sdMMLYHuggKHguYoH3QhYjymHPEOuDI-xWEcCgwPgQdgglNRMK64GqSLgaz0ePs8_1jXC7CxFFW5oU1WW10VKk6N0Xto7yIUl-rYtmsL6N5457N9hgcWLX25mS3e-Dp5no-nsTTh9t0PJrGGQ2nY6zDN5hoSqzmigtGoM6owApDZZWxXBjKEqYVwgaxZYaJ5RrBhAdgKDglPXDeeitXvjTG13JVNq4IJyWmlIshp0gE6qKlMld674yVlcs3ym0lgvK7kgyV5E-lwJ7tjM1yY_Qf-ZslAIMWeMvXZvu_Sd7dL1rlFzvucBU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2446986419</pqid></control><display><type>article</type><title>HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Altuntas Aydin, Ozlem ; Kumbasar Karaosmanoglu, Hayat ; Kart Yasar, Kadriye</creator><creatorcontrib>Altuntas Aydin, Ozlem ; Kumbasar Karaosmanoglu, Hayat ; Kart Yasar, Kadriye</creatorcontrib><description>Highlights
COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment.
Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases.
Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.25955</identifier><identifier>PMID: 32347975</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Antibodies ; Antiretroviral therapy ; CD4 antigen ; CD4 Lymphocyte Count ; Coinfection - epidemiology ; Coinfection - virology ; Comorbidity ; COVID-19 ; COVID-19 - diagnostic imaging ; COVID-19 - epidemiology ; HIV ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; Human immunodeficiency virus ; Humans ; Male ; Public health ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Tomography, X-Ray Computed ; Turkey - epidemiology ; Virology</subject><ispartof>Journal of medical virology, 2020-11, Vol.92 (11), p.2288-2290</ispartof><rights>2020 Wiley Periodicals LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4615-2d90723d43fd6a69530dc492a20afaef69e4575da12e15bc23f6d1076a2089643</citedby><cites>FETCH-LOGICAL-c4615-2d90723d43fd6a69530dc492a20afaef69e4575da12e15bc23f6d1076a2089643</cites><orcidid>0000-0001-8035-1385</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32347975$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Altuntas Aydin, Ozlem</creatorcontrib><creatorcontrib>Kumbasar Karaosmanoglu, Hayat</creatorcontrib><creatorcontrib>Kart Yasar, Kadriye</creatorcontrib><title>HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey</title><title>Journal of medical virology</title><addtitle>J Med Virol</addtitle><description>Highlights
COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment.
Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases.
Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals.</description><subject>Adult</subject><subject>Antibodies</subject><subject>Antiretroviral therapy</subject><subject>CD4 antigen</subject><subject>CD4 Lymphocyte Count</subject><subject>Coinfection - epidemiology</subject><subject>Coinfection - virology</subject><subject>Comorbidity</subject><subject>COVID-19</subject><subject>COVID-19 - diagnostic imaging</subject><subject>COVID-19 - epidemiology</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Male</subject><subject>Public health</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Tomography, X-Ray Computed</subject><subject>Turkey - epidemiology</subject><subject>Virology</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKw0AUQAdRbK0u_AEJuBJMO-903JWiNlIRbO12mGZmILVN4kyidOcn-I1-iaOp7tzcuzmcezkAnCLYRxDiwWrz2sdMMLYHuggKHguYoH3QhYjymHPEOuDI-xWEcCgwPgQdgglNRMK64GqSLgaz0ePs8_1jXC7CxFFW5oU1WW10VKk6N0Xto7yIUl-rYtmsL6N5457N9hgcWLX25mS3e-Dp5no-nsTTh9t0PJrGGQ2nY6zDN5hoSqzmigtGoM6owApDZZWxXBjKEqYVwgaxZYaJ5RrBhAdgKDglPXDeeitXvjTG13JVNq4IJyWmlIshp0gE6qKlMld674yVlcs3ym0lgvK7kgyV5E-lwJ7tjM1yY_Qf-ZslAIMWeMvXZvu_Sd7dL1rlFzvucBU</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Altuntas Aydin, Ozlem</creator><creator>Kumbasar Karaosmanoglu, Hayat</creator><creator>Kart Yasar, Kadriye</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0001-8035-1385</orcidid></search><sort><creationdate>202011</creationdate><title>HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey</title><author>Altuntas Aydin, Ozlem ; Kumbasar Karaosmanoglu, Hayat ; Kart Yasar, Kadriye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4615-2d90723d43fd6a69530dc492a20afaef69e4575da12e15bc23f6d1076a2089643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Antibodies</topic><topic>Antiretroviral therapy</topic><topic>CD4 antigen</topic><topic>CD4 Lymphocyte Count</topic><topic>Coinfection - epidemiology</topic><topic>Coinfection - virology</topic><topic>Comorbidity</topic><topic>COVID-19</topic><topic>COVID-19 - diagnostic imaging</topic><topic>COVID-19 - epidemiology</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Male</topic><topic>Public health</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Tomography, X-Ray Computed</topic><topic>Turkey - epidemiology</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Altuntas Aydin, Ozlem</creatorcontrib><creatorcontrib>Kumbasar Karaosmanoglu, Hayat</creatorcontrib><creatorcontrib>Kart Yasar, Kadriye</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Altuntas Aydin, Ozlem</au><au>Kumbasar Karaosmanoglu, Hayat</au><au>Kart Yasar, Kadriye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J Med Virol</addtitle><date>2020-11</date><risdate>2020</risdate><volume>92</volume><issue>11</issue><spage>2288</spage><epage>2290</epage><pages>2288-2290</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><abstract>Highlights
COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment.
Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases.
Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32347975</pmid><doi>10.1002/jmv.25955</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-8035-1385</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0146-6615 |
| ispartof | Journal of medical virology, 2020-11, Vol.92 (11), p.2288-2290 |
| issn | 0146-6615 1096-9071 |
| language | eng |
| recordid | cdi_proquest_journals_2446986419 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Adult Antibodies Antiretroviral therapy CD4 antigen CD4 Lymphocyte Count Coinfection - epidemiology Coinfection - virology Comorbidity COVID-19 COVID-19 - diagnostic imaging COVID-19 - epidemiology HIV HIV Infections - drug therapy HIV Infections - epidemiology Human immunodeficiency virus Humans Male Public health Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Tomography, X-Ray Computed Turkey - epidemiology Virology |
| title | HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A25%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIV/SARS%E2%80%90CoV%E2%80%902%20coinfected%20patients%20in%20Istanbul,%20Turkey&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Altuntas%20Aydin,%20Ozlem&rft.date=2020-11&rft.volume=92&rft.issue=11&rft.spage=2288&rft.epage=2290&rft.pages=2288-2290&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.25955&rft_dat=%3Cproquest_cross%3E2446986419%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4615-2d90723d43fd6a69530dc492a20afaef69e4575da12e15bc23f6d1076a2089643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2446986419&rft_id=info:pmid/32347975&rfr_iscdi=true |